4893 items matching your search terms.

The Goldilocks principle. Oxygen in the delivery room: When is it too little, too much, and just right?

Kapadia, V. Rabi, Y. Oei, J. L.
SEMINARS IN FETAL AND NEONATAL MEDICINE, 2018     DOI:10.1016/j.siny.2018.06.003

Subclinical first trimester renal abnormalities are associated with preeclampsia in normoalbuminuric women with type 1 diabetes

Kelly, C. B. Hookham, M. B. Yu, J. Y. Jenkins, A. J. Nankervis, A. J. Hanssen, K. F. Garg, S. K. Scardo, J. A. Hammad, S. M. Menard, M. K. Aston, C. E. Lyons, T. J.
DIABETES CARE, 2018     DOI:10.2337/dc17-1635

Response to Comment on Kelly et al. Subclinical first trimester renal abnormalities are associated with preeclampsia in normoalbuminuric women with type 1 diabetes. Diabetes Care 2018;41:120-127

Kelly, C. B. Hookham, M. B. Yu, J. Y. Jenkins, A. J. Nankervis, A. J. Hanssen, K. F. Garg, S. K. Scardo, J. A. Hammad, S. M. Menard, M. K. Aston, C. E. Lyons, T. J.
DIABETES CARE, 2018     DOI:10.2337/dci18-0006

Total hip arthroplasty by the direct anterior approach using a neck-preserving stem: Safety, efficacy and learning curve

Khemka, A. Mograby, O. Lord, S. J. Doyle, Z. Al Muderis, M.
INDIAN J ORTHOP, 2018     DOI:10.4103/ortho.IJOrtho_314_16

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

King, M. T. Stockler, M. R. O'Connell, R. L. Buizen, L. Joly, F. Lanceley, A. Hilpert, F. Okamoto, A. Aotani, E. Bryce, J. Donnellan, P. Oza, A. Avall-Lundqvist, E. Berek, J. S. Sehouli, J. Feeney, A. Berton-Rigaud, D. Costa, D. S. J. Friedlander, M. L. Gcig Symptom Benefit group
QUALITY OF LIFE RESEARCH, 2018     DOI:10.1007/s11136-017-1729-8

Stereotactic body radiotherapy for oligometastatic prostate cancer detected via prostate-specific membrane antigen positron emission tomography

Kneebone, A. Hruby, G. Ainsworth, H. Byrne, K. Brown, C. Guo, L. Guminski, A. Eade, T.
EUR UROL ONCOL, 2018     DOI:10.1016/j.euo.2018.04.017

Predicting the effect of fenofibrate on cardiovascular risk for individual patients with type 2 diabetes

Koopal, C. Visseren, F. L. J. Westerink, J. van der Graaf, Y. Ginsberg, H. N. Keech, A. C.
DIABETES CARE, 2018     DOI:10.2337/dc17-0968

Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients

Krishnasamy, R. Hawley, C. M. Jardine, M. J. Roberts, M. A. Cho, Y. J. Wong, M. G. Heath, A. Nelson, C. L. Sen, S. Mount, P. F. Pascoe, E. M. Darssan, D. Vergara, L. A. Paul-Brent, P. A. Toussaint, N. D. Johnson, D. W. Hutchison, C. A.
BMC NEPHROLOGY, 2018     DOI:10.1186/s12882-018-0883-8

Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion

Lam, J. K. S. Sundaresan, P. Gebski, V. Veness, M. J.
HEAD AND NECK, 2018     DOI:10.1002/hed.25069

Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common

Larsson, C. R. Januszewski, A. S. McGrath, R. T. Ludvigsson, J. Keech, A. C. MacIsaac, R. J. Ward, G. M. O'Neal, D. N. Fulcher, G. R. Jenkins, A. J.
INTERNAL MEDICINE JOURNAL, 2018     DOI:10.1111/imj.13798

Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours

Lawrence, N. J. Chan, H. Toner, G. Stockler, M. R. Martin, A. Yip, S. Wong, N. Yeung, A. Mazhar, D. Pashankar, F. Frazier, L. McDermott, R. Walker, R. Tan, H. Davis, I. D. Grimison, P. Anzup,
BMC CANCER, 2018     DOI:10.1186/s12885-018-4745-3

What survival benefits are needed to make adjuvant sorafenib worthwhile after resection of intermediate- or high-risk renal cell carcinoma? Clinical investigators' preferences in the SORCE trial

Lawrence, N. J. Martin, A. Davis, I. D. Troon, S. Sengupta, S. Hovey, E. Coskinas, X. Kaplan, R. Smith, B. Ritchie, A. Meade, A. Eisen, T. Blinman, P. Stockler, M. R.
KIDNEY CANCER, 2018     DOI:10.3233/KCA-180038

Effect sizes hypothesized and observed in contemporary phase III trials of targeted and immunological therapies for advanced cancer

Lawrence, N. J. Roncolato, F. Martin, A. Simes, R. J. Stockler, M. R.
JNCI CANCER SPECTR, 2018     DOI:10.1093/jncics/pky037

When do patient reported quality of life indicators become prognostic in breast cancer?

Lee, C. K. Hudson, M. Simes, J. Ribi, K. Bernhard, J. Coates, A. S.
HEALTH AND QUALITY OF LIFE OUTCOMES, 2018     DOI:10.1186/s12955-017-0834-2

The value of early depth of response in predicting long-term outcome in EGFR-mutant lung cancer

Lee, C. K. Lord, S. Marschner, I. Wu, Y. L. Sequist, L. Rosell, R. Fukuoka, M. Mitsudomi, T. Asher, R. Davies, L. Gebski, V. Gralla, R. Mok, T. Chih-Hsin Yang, J.
JOURNAL OF THORACIC ONCOLOGY, 2018     DOI:10.1016/j.jtho.2018.03.010